This CAR not only used the SynNotch receptor as a switch for tumor antigen recognition, but also had dual-target recognition specificity for GPC3 and CD147, which further limited CAR to selectively recognize GPC3+CD147+ liver cancer cells. The gene discussed is GPC3; the disease is liver cancer.